HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cytogenetic disorders in peripheral blood lymphocytes of patients with febrile form of tick-borne encephalitis.

Abstract
An appreciable increase in the number of aberrant lymphocytes was detected in the peripheral blood of patients with febrile form of tick-borne encephalitis (TBE). This increase peaked during week 2 of the infectious process and was paralleled by a decrease in the count of natural killer cells. By the end of the acute period of neuroinfection the number of cells with structural chromosome aberrations decreased, but still surpassed the control (donor blood). Genetically unstable cells were eliminated predominantly at the expense of lymphocytes with chromatid disorders, while the count of CD16-expressing lymphocytes increased. The intensity of reparative DNA synthesis was suppressed during the entire acute period of tick-borne encephalitis.
AuthorsN P Pirogova, V V Novitskii, O V Mikhailova, M Yu Khlusova, L V Babaeva, O V Voronkova, A P Mel'nikova, M R Karpova, L V Lukasheva
JournalBulletin of experimental biology and medicine (Bull Exp Biol Med) Vol. 137 Issue 1 Pg. 61-3 (Jan 2004) ISSN: 0007-4888 [Print] United States
PMID15085248 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Receptors, IgG
  • DNA
Topics
  • Adult
  • Chromosome Aberrations
  • DNA (biosynthesis)
  • DNA Repair
  • Encephalitis Viruses, Tick-Borne (pathogenicity)
  • Encephalitis, Tick-Borne (blood, genetics)
  • Female
  • Fever (virology)
  • Humans
  • Lymphocytes (blood, immunology, ultrastructure)
  • Male
  • Middle Aged
  • Receptors, IgG (analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: